Roles of kinins in the nervous system

Cell Transplantation

Volumn 24, Issue 4, 2015, Pages 613-623

  Negraes, Priscilla D ^a   Trujillo, Cleber A ^b   Pillat, Micheli M ^a   Teng, Yang D ^c   Ulrich, Henning ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

B1BKR and B2BKR; Bradykinin; Inflammation; Neural differentiation; Neuroprotection

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; KININ; BRADYKININ RECEPTOR;

BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; ISCHEMIA; KALLIKREIN KININ SYSTEM; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; ANIMAL; CYTOLOGY; METABOLISM;

ANIMALS; HUMANS; KININS; NERVOUS SYSTEM; NEURAL STEM CELLS; NEUROGENESIS; RECEPTORS, BRADYKININ; SPINAL CORD INJURIES;

EID: 84927620485     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X687778     Document Type: Review

References (100)

1. Adolfo Argañaraz, G.; Regina Perosa, S.; Cristina Lencioni, E.; Bader, M.; Abrão Cavalheiro, E.; da Graça NaffahMazzacoratti, M.; Pesquero, J. B.; Antônio Silva, J. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy. Brain Res. 1013:30–39; 2004.
2. Adomeit, A.; Graness, A.; Gross, S.; Seedorf, K.; Wetzker, R.; Liebmann, C. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol. Cell.Biol. 19:5289–5297; 1999.
3. Albert-Weissenberger, C.; Stetter, C.; Meuth, S. G.; Göbel, K.; Bader, M.; Sirén, A.-L.; Kleinschnitz, C., Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J. Cereb. Blood Flow Metab. 32:1747–1756; 2012.
4. Ali, F.; Hindley, C.; McDowell, G.; Deibler, R.; Jones, A.; Kirschner, M.; Guillemot, F.; Philpott, A. Cell cycleregulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Development 138:4267–4277; 2011.
5. Alric, C.; Pecher, C.; Bascands, J. L.; Girolami, J. P. Effect of bradykinin on tyrosine kinase and phosphatase activities and cell proliferation in mesangial cells. Immunopharmacology 45:57–62; 1999.
6. Appell, K. C.; Barefoot, D. S. Neurotransmitter release from bradykinin-stimulated PC12 cells. Stimulation of cytosolic calcium and neurotransmitter release. Biochem. J. 263:11–18; 1989.
7. Austinat, M.; Braeuninger, S.; Pesquero, B.; Brede, M.; Bader, M.; Stoll, G.; Renne, T.; Kleinschnitz, C.; Pesquero, J. B.; Renné, T. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 40:285–293; 2009.
8. Bannister, K.; Lee, Y. S.; Goncalves, L.; Porreca, F.; Lai, J.; Dickenson, A. H. Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Neuropharmacology 85:375–383; 2014.
9. Bebien, M.; Hensler, M. E.; Davanture, S.; Hsu, L.-C.; Karin, M.; Park, J. M.; Alexopoulou, L.; Liu, G. Y.; Nizet, V.; Lawrence, T. The pore-forming toxin b hemolysin/ cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog. 8:e1002812; 2012.
10. Bhoola, K. D.; Figueroa, C. D.; Worthy, K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44:1–80; 1992.
11. Borkowski, J. A.; Hess, J. F. Targeted disruption of the mouse B2 bradykinin receptor in embryonic stem cells. Can. J. Physiol. Pharmacol. 73:773–779; 1995.
12. Camacho, A.; Massieu, L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37:11–18; 2006.
13. Cameron, H.A.; Hazel, T.G.; McKay, R.D., Regulation of neurogenesis by growth factors and neurotransmitters. J. Neurobiol. 36:287–306; 1998.
14. Campbell, D. J. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol. 28:1060–1065; 2001.
15. Chao, J.; Chao, L.; Swain, C.C.; Tsai, J.; Margolius, H.S., Tissue kallikrein in rat brain and pituitary: Regional distribution and estrogen induction in the anterior pituitary. Endocrinology. 120:475–482; 1987.
16. Damas, J.; Delrée, P.; Bourdon, V. Distribution of immunoreactive T-kininogen in rat nervous tissues. Brain Res. 569:63–70; 1992.
17. Diamandis, E. P.; Scorilas, A.; Kishi, T.; Blennow, K.; Luo, L.-Y.; Soosaipillai, A.; Rademaker, A. W.; Sjogren, M. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer’s disease and frontotemporal dementia. Clin. Biochem. 37:230–237; 2004.
18. Diamandis, E. P.; Yousef, G. M.; Petraki, C.; Soosaipillai, A. R. Human kallikrein 6 as a biomarker of alzheimer’s disease. Clin Biochem. 33:663–667; 2000.
19. Dikic, I.; Tokiwa, G.; Lev, S.; Courtneidge, S. A.; Schlessinger, J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383:547–550; 1996.
20. Dixon, B. S.; Evanoff, D.; Fang, W. B.; Dennis, M. J. Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1. Am J Physiol Cell Physiol. 283:C193–C203; 2002.
21. DomBourian, M. G.; Turner, N. A.; Gerovac, T. A.; Vemuganti, R.; Miranpuri, G. S.; Türeyen, K.; Satriotomo, I.; Miletic, V.; Resnick, D. K. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine.(Phila. Pa. 1976). 31:2778–2782; 2006.
22. Duchene, J.; Schanstra, J. P.; Pecher, C.; Pizard, A.; Susini, C.; Esteve, J. P.; Bascands, J. L.; Girolami, J.P.. A novel protein-protein interaction between a G proteincoupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J. Biol. Chem. 277:40375–40383; 2002.
23. Emerich, D. F.; Dean, R. L.; Osborn, C.; Bartus, R. T. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: From concept to clinical evaluation. Clin. Pharmacokinet. 40:105–123; 2001.
24. Erdös, E. G. The ACE and I: How ACE inhibitors came to be. FASEB J. 20:1034–1038; 2006.
25. Ferreira, J.; Beirith, A.; Mori, M. A. S.; Araújo, R. C.; Bader, M.; Pesquero, J. B.; Calixto, J. B. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J. Neurosci. 25:2405–2412; 2005.
26. Francel, P.C.. Bradykinin and neuronal injury. J. Neurotrauma 9 Suppl.1:S27–S45; 1992.
27. Fujieda, H.; Sato, T.; Wake, K.; Takaoka, M.; Morimoto, S. Tissue kallikrein in the rat pineal gland: An immunocytochemical study. J. Pineal Res. 14:84–88; 1993.
28. Ginsberg, M.D., Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55:363–389; 2009.
29. Göbel, K.; Pankratz, S.; Schneider-Hohendorf, T.; Bittner, S.; Schuhmann, M. K.; Langer, H. F.; Stoll, G.; Wiendl, H.; Kleinschnitz, C.; Meuth, S. G. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J. Autoimmun. 36:106–114; 2011.
30. Golias, C.; Charalabopoulos, A.; Stagikas, D.; Charalabopoulos, K.; Batistatou, A. The kinin system-bradykinin: Biological effects and clinical implications. Multiple role of the kinin system--bradykinin. Hippokratia 11:124–128; 2007.
31. Gómez-López, S.; Lerner, R. G.; Petritsch, C. Asymmetric cell division of stem and progenitor cells during homeostasis and cancer. Cell. Mol. Life Sci. 71:575–597; 2014.
32. Hawgood, B.J., Maurício Rocha e Silva M. D. Snake venom, bradykinin and the rise of autopharmacology. Toxicon. 35:1569–1580; 1997.
33. Huttner, W.B.; Brand, M., Asymmetric division and polarity of neuroepithelial cells. Curr. Opin. Neurobiol. 7:29–39; 1997.
34. Ignjatovic, T.; Tan, F.; Brovkovych, V.; Skidgel, R. A.; Erdös, E. G. Activation of bradykinin B1 receptor by ACE inhibitors. Int. Immunopharmacol. 2:1787–1793; 2002.
35. Ignjatovic, T.; Tan, F.; Brovkovych, V.; Skidgel, R. A.; Erdös, E. G. Novel mode of action of angiotensin I converting enzyme inhibitors: Direct activation of bradykinin B1 receptor. J. Biol. Chem. 277:16847–16852; 2002.
36. Iwadate, H.; Kudo, M.; Kizuki, K. Expression of tissue kallikrein mRNA in developing rat brains. Can. J. Physiol. Pharmacol. 80:245–248; 2002.
37. Jäderstad, J.; Jäderstad, L. M.; Li, J.; Chintawar, S.; Salto, C.; Pandolfo, M.; Ourednik, V.; Teng, Y. D.; Sidman, R. L.; Arenas, E.; Snyder, E. Y.; Herlenius, E. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc. Natl. Acad. Sci. USA. 107:5184–5189; 2010.
38. Jain, K.K., Neuroprotection in traumatic brain injury. Drug Discov. Today 13:1082–1089; 2008.
39. Kamiya, T.; Katayama, Y.; Kashiwagi, F.; Terashi, A. The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24:571–575; discussion 575–576; 1993.
40. Kamiya, T. [Studies on the involvement of bradykinin in the formation of ischemic brain edema]. Nihon Ika Daigaku Zasshi 57:180–191; 1990.
41. Kläsner, B.; Lumenta, D. B.; Pruneau, D.; Zausinger, S.; Plesnila, N. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats. Neurochem. Int. 49:442–447; 2006.
42. Kleinschnitz, C.; Austinat, M.; Bader, M.; Renné, T.; Stoll, G. Deficiency of bradykinin receptor B2 is not detrimental in experimental stroke. Hypertension. 51:e41; author reply e42–e43; 2008.
43. Kozlowski, M. R.; Rosser, M. P.; Hall, E.; Longden, A. Effects of bradykinin on PC-12 cell differentiation. Peptides 10:1121–1126; 1989.
44. Langhauser, F.; Göb, E.; Kraft, P.; Geis, C.; Schmitt, J.; Brede, M.; Göbel, K.; Helluy, X.; Pham, M.; Bendszus, M.; Jakob, P.; Stoll, G.; Meuth, S. G.; Nieswandt, B.; McCrae, K. R.; Kleinschnitz, C. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood 120:4082–4092; 2012.
45. Leclerc, C.; Néant, I.; Moreau, M. The calcium: An early signal that initiates the formation of the nervous system during embryogenesis. Front. Mol. Neurosci. 5:3; 2012.
46. Lee, K. Y.; Gold, M. S. Inflammatory mediators potentiate high affinity GABA(A) currents in rat dorsal root ganglion neurons. Neurosci. Lett. 518:128–132; 2012.
47. Lewis, J., Neurogenic genes and vertebrate neurogenesis. Curr. Opin. Neurobiol. 6:3–10; 1996.
48. Liu, J. X.; Pinnock, S. B.; Herbert, J. Novel control by the CA3 region of the hippocampus on neurogenesis in the dentate gyrus of the adult rat. PLoS One 6:e17562; 2011.
49. Madeddu, P.; Varoni, M. V.; Palomba, D.; Emanueli, C.; Demontis, M. P.; Glorioso, N.; Dessì-Fulgheri, P.; Sarzani, R.; Anania, V. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96:3570–3578; 1997.
50. Mahabeer, R.; Naidoo, S.; Raidoo, D. M. Detection of tissue kallikrein and kinin B1 and B2 receptor mRNAs in human brain by in situ RT-PCR. Metab. Brain Dis. 15:325–335; 2000.
51. Marceau, F.; Regoli, D. Bradykinin receptor ligands: Therapeutic perspectives. Nat. Rev. Drug Discov. 3:845– 852; 2004.
52. Martínez-Morillo, E.; Diamandis, A.; Romaschin, A. D.; Diamandis, E. P. Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. PLoS One 7:e45676; 2012.
53. Martins, A. H.; Alves, J. M.; Perez, D.; Carrasco, M.; Torres-Rivera, W.; Eterović, V. A.; Ferchmin, P. A.; Ulrich, H. Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists. PLoS One 7:e30755; 2012.
54. Martins, A. H.; Alves, J. M.; Trujillo, C. A.; Schwindt, T. T.; Barnabé, G. F.; Motta, F. L. T.; Guimaraes, A. O.; Casarini, D. E.; Mello, L. E.; Pesquero, J. B.; Ulrich, H. Kinin-B2 receptor expression and activity during differentiation of embryonic rat neurospheres. Cytometry A. 73:361–368; 2008.
55. Martins, A. H. B.; Resende, R. R.; Majumder, P.; Faria, M.; Casarini, D. E.; Tárnok, A.; Colli, W.; Pesquero, J. B.; Ulrich, H., Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. J. Biol. Chem. 280:19576–19586; 2005.
56. McConnell, S.K., Constructing the cerebral cortex: Neurogenesis and fate determination. Neuron 15:761–768; 1995.
57. McGarry, T. J.; Kirschner, M. W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93:1043–1053; 1998.
58. Mechírová, E.; Danielisová, V.; Domoráková, I.; Danková, M.; Stebnický, M.; Mičková, H.; Burda, J. Bradykinin preconditioning affects the number of degenerated neurons and the level of antioxidant enzymes in spinal cord ischemia in rabbits. Acta Histochem. 116:252–257; 2014.
59. Meneton, P.; Bloch-Faure, M.; Hagege, A. A.; Ruetten, H.; Huang, W.; Bergaya, S.; Ceiler, D.; Gehring, D.; Martins, I.; Salmon, G.; Boulanger, C. M.; Nussberger, J.; Crozatier, B.; Gasc, J. M.; Heudes, D.; Bruneval, P.; Doetschman, T.; Ménard, J.; Alhenc-Gelas, F. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc. Natl. Acad. Sci. USA. 98:2634–2639; 2001.
60. Moreau, M. E.; Garbacki, N.; Molinaro, G.; Brown, N. J.; Marceau, F.; Adam, A. The kallikrein-kinin system: Current and future pharmacological targets. J. Pharmacol. Sci. 99:6–38; 2005.
61. Naffah-Mazzacoratti, M. da G.; Gouveia, T. L. F.; Simões, P. S. R.; Perosa, S. R. What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders? World J. Biol. Chem. 5:130–140; 2014.
62. Noda, M.; Kariura, Y.; Amano, T.; Manago, Y.; Nishikawa, K.; Aoki, S.; Wada, K., Kinin receptors in cultured rat microglia. Neurochem Int. 45:437–442.
63. Noda, M.; Kariura, Y.; Pannasch, U.; Nishikawa, K.; Wang, L.; Seike, T.; Ifuku, M.; Kosai, Y.; Wang, B.; Nolte, C.; Aoki, S.; Kettenmann, H.; Wada, K. Neuroprotective role of bradykinin because of the attenuation of proinflammatory cytokine release from activated microglia. J. Neurochem. 101:397–410; 2007.
64. Ohnuma, S.I.; Philpott, A.; Harris, W.A., Cell cycle and cell fate in the nervous system. Curr. Opin. Neurobiol. 11:66–73; 2001.
65. Orford, K. W.; Scadden, D. T. Deconstructing stem cell self-renewal: Genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9:115–128; 2008.
66. Pan, W.; Kastin, A. J.; Gera, L.; Stewart, J. M. Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice. Neurosci. Lett. 307:25–28; 2001.
67. Patel, K.V; Schrey, M.P., Inhibition of DNA synthesis and growth in human breast stromal cells by bradykinin: Evidence for independent roles of B1 and B2 receptors in the respective control of cell growth and phospholipid hydrolysis. Cancer Res. 52:334–340; 1992.
68. Perosa, S. R.; Argañaraz, G. A.; Goto, E. M.; Costa, L. G. P.; Konno, A. C.; Varella, P. P. V.; Santiago, J. F. C.; Pesquero, J. B.; Canzian, M.; Amado, D.; Yacubian, E. M.; Carrete, H.; Centeno, R. S.; Cavalheiro, E. A.; Silva, J. A.; Mazzacoratti, M. G.N. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy. Hippocampus 17:26–33; 2007.
69. Pesquero, J. B.; Araujo, R. C.; Heppenstall, P. A.; Stucky, C. L.; Silva, J. A.; Walther, T.; Oliveira, S. M.; Pesquero, J. L.; Paiva, A. C.; Calixto, J. B.; Lewin, G. R.; Bader, M., Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. USA 97:8140–8145; 2000.
70. Pesquero, J. B.; Bader, M. Genetically altered animal models in the kallikrein-kinin system. Biol. Chem. 387:119– 126; 2006.
71. Petcu, M.; Dias, J. P.; Ongali, B.; Thibault, G.; Neugebauer, W.; Couture, R. Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. Int. Immunopharmacol. 8:188–196; 2008.
72. Plesnila, N.; Schulz, J.; Stoffel, M.; Eriskat, J.; Pruneau, D.; Baethmann, A. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats. J. Neurotrauma 18:1049–1058; 2001.
73. Powers, C. A.; Nasjletti, A. A kininogenase resembling glandular kallikrein in the rat pituitary pars intermedia. Endocrinology 112:1194–1200; 1983.
74. Raidoo, D. M.; Bhoola, K. D. Kinin receptors on human neurones. J. Neuroimmunol. 77:39–44; 1997.
75. Rajpal, S.; Gerovac, T. A.; Turner, N. A.; Tilghman, J. I.; Allcock, B. K.; McChesney, S. L.; Miranpuri, G. S.; Park, S. W.; Resnick, D.K.. Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats. J. Neurosurg. Spine 6:420–424; 2007.
76. Raslan, F.; Schwarz, T.; Meuth, S. G.; Austinat, M.; Bader, M.; Renné, T.; Roosen, K.; Stoll, G.; Sirén, A.-L.; Kleinschnitz, C., Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab. 30:1477–1486; 2010.
77. Rocha e Silva, M.; Beraldo, W. T.; Rosenfeld, G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. A.J. Physiol. 156:261–273; 1949.
78. Santos, S. D. M.; Verveer, P. J.; Bastiaens, P. I. H. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9:324–330; 2007.
79. Sasagawa, S.; Ozaki, Y.; Fujita, K.; Kuroda, S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 7:365–373; 2005.
80. Scarisbrick, I. A.; Linbo, R.; Vandell, A. G.; Keegan, M.; Blaber, S. I.; Blaber, M.; Sneve, D.; Lucchinetti, C. F.; Rodriguez, M.; Diamandis, E.P.. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol.Chem. 389:739–745; 2008.
81. Schouten, J.J.W.. Neuroprotection in traumatic brain injury: A complex struggle against the biology of nature. Curr. Opin. Crit. Care 13:134–142; 2007.
82. Schuelert, N.; Just, S.; Corradini, L.; Kuelzer, R.; Bernloehr, C.; Doods, H. The bradykinin B1 receptor antagonist BI113823 reverses inflammatory hyperalgesia by desensitization of peripheral and spinal neurons. Eur. J. Pain 19:132–142; 2015.
83. Su, J.; Cui, M.; Tang, Y.; Zhou, H.; Liu, L.; Dong, Q., Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. Biochem. Biophys. Res. Commun. 388:205–211; 2009.
84. Teng, Y. D.; Mocchetti, I.; Taveira-DaSilva, A. M.; Gillis, R. A.; Wrathall, J.R.. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J. Neurosci. 19:7037–7047; 1999.
85. Teng, Y. D.; Yu, D.; Ropper, A. E.; Li, J.; Kabatas, S.; Wakeman, D. R.; Wang, J.; Sullivan, M. P.; Redmond, D. E.; Langer, R.; Snyder, E. Y.; Sidman, R. L. Functional multipotency of stem cells: A conceptual review of neurotrophic factor-based evidence and its role in translational research. Curr. Neuropharmacol. 9:574–585; 2011.
86. Thornton, E.; Ziebell, J. M.; Leonard, A. V; Vink, R. Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules 15:6598–6618; 2010.
87. Trabold, R.; Erös, C.; Zweckberger, K.; Relton, J.; Beck, H.; Nussberger, J.; Müller-Esterl, W.; Bader, M.; Whalley, E.; Plesnila, N. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 30:130–139; 2010.
88. Trujillo, C. A.; Negraes, P. D.; Schwindt, T. T.; Lameu, C.; Carromeu, C.; Muotri, A. R.; Pesquero, J. B.; Cerqueira, D. M.; Pillat, M. M.; de Souza, H. D. N.; Turaca, L. T.; Abreu, J. G.; Ulrich, H. Kinin-B2 receptor activity determines the differentiation fate of neural stem cells. J. Biol. Chem. 287:44046–44061; 2012.
89. Viel, T. A.; Buck, H. S. Kallikrein-kinin system mediated inflammation in Alzheimer’s disease in vivo. Curr. Alzheimer Res. 8:59–66; 2011.
90. Willis, W.D., Dorsal root potentials and dorsal root reflexes: A double-edged sword. Exp Brain Res. 124:395– 421; 1999.
91. Xia, C.; Yin, H.; Yao, Y.-Y.; Borlongan, C. V; Chao, L. E. E.; Chao, J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum. Gene Ther. 17:206–219; 2006.
92. Xia, C.-F.; Smith, R. S.; Shen, B.; Yang, Z.-R.; Borlongan, C. V; Chao, L.; Chao, J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 47:752–761; 2006.
93. Xia, C.-F.; Yin, H.; Borlongan, C. V; Chao, L.; Chao, J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43:452–459; 2004.
94. Xu, J.; Hsu, C. Y.; Junker, H.; Chao, S.; Hogan, E. L.; Chao, J., Kininogen and kinin in experimental spinal cord injury. J. Neurochem. 57:975–980; 1991.
95. Xu, W.; Gu, Y.; Wang, Y.; Lu, X.; Jia, L.; Lv, G. Bradykinin preconditioning modulates aquaporin-4 expression after spinal cord ischemic injury in rats. Brain Res. 1246:11–18; 2008.
96. Yan-Feng, W.; Gang, L.; Yan-Ting, G. Bradykinin preconditioning induces protective effects on the spinal cord ischemic injury of rats. Neurosci. Lett. 433:114–118; 2008.
97. Yasuyoshi, H.; Kashii, S.; Zhang, S.; Nishida, A.; Yamauchi, T.; Honda, Y.; Asano, Y.; Sato, S.; Akaike, A. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest. Ophthalmol. Vis. Sci. 41:2273–2278; 2000.
98. Yin, H.; Chao, L.; Chao, J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Aktglycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J. Biol. Chem. 280:8022–8030; 2005.
99. Yoshida, H.; Zhang, J. J.; Chao, L.; Chao, J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35:25–31; 2000.
100. Zweckberger, K.; Plesnila, N. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. Neurosci. Lett. 454:115–117; 2009.